Colette DeJong

1.3k total citations · 2 hit papers
26 papers, 696 citations indexed

About

Colette DeJong is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and General Health Professions. According to data from OpenAlex, Colette DeJong has authored 26 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in General Health Professions. Recurrent topics in Colette DeJong's work include Pharmaceutical Economics and Policy (10 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Medication Adherence and Compliance (6 papers). Colette DeJong is often cited by papers focused on Pharmaceutical Economics and Policy (10 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Medication Adherence and Compliance (6 papers). Colette DeJong collaborates with scholars based in United States, Australia and Japan. Colette DeJong's co-authors include R. Adams Dudley, Chien‐Wen Tseng, W. John Boscardin, Grace A. Lin, Dhruv S. Kazi, Randi Chen, Mitzi L. Dean, Jason M. Davies, Ben J. Marafino and Catherine R. Lucey and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Colette DeJong

23 papers receiving 671 citations

Hit Papers

Pharmaceutical Industry–Sponsored Meals and Physician Pre... 2016 2026 2019 2022 2016 2024 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colette DeJong United States 12 316 306 178 118 65 26 696
Frank Davidoff United States 10 111 0.4× 284 0.9× 424 2.4× 273 2.3× 28 0.4× 19 1.0k
Shantanu Agrawal United States 12 321 1.0× 327 1.1× 252 1.4× 131 1.1× 26 0.4× 30 684
Beth Fylan United Kingdom 12 65 0.2× 124 0.4× 234 1.3× 54 0.5× 50 0.8× 42 595
Niall Brennan United States 12 121 0.4× 281 0.9× 287 1.6× 64 0.5× 101 1.6× 25 555
Adam Licurse United States 15 93 0.3× 129 0.4× 322 1.8× 237 2.0× 30 0.5× 24 707
Jamie R. Robinson United States 15 64 0.2× 48 0.2× 107 0.6× 101 0.9× 45 0.7× 48 820
Alessandra Ferrario United Kingdom 15 130 0.4× 648 2.1× 159 0.9× 90 0.8× 66 1.0× 40 1.2k
Robert M. Hartley United States 8 347 1.1× 363 1.2× 223 1.3× 112 0.9× 50 0.8× 13 728
Mark Makowsky Canada 15 45 0.1× 108 0.4× 321 1.8× 140 1.2× 109 1.7× 37 952
Christopher Truffer United States 9 38 0.1× 486 1.6× 435 2.4× 124 1.1× 51 0.8× 9 968

Countries citing papers authored by Colette DeJong

Since Specialization
Citations

This map shows the geographic impact of Colette DeJong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colette DeJong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colette DeJong more than expected).

Fields of papers citing papers by Colette DeJong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colette DeJong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colette DeJong. The network helps show where Colette DeJong may publish in the future.

Co-authorship network of co-authors of Colette DeJong

This figure shows the co-authorship network connecting the top 25 collaborators of Colette DeJong. A scholar is included among the top collaborators of Colette DeJong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colette DeJong. Colette DeJong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdullah, Abdul R., Suzanne V. Arnold, Anirban Basu, et al.. (2025). 2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement). Journal of the American College of Cardiology. 87(9). 1177–1206.
2.
DeJong, Colette, Mansi Agarwal, Matthew S. Durstenfeld, et al.. (2025). Developing a Multilevel Polypill Implementation Bundle for Patients With Heart Failure With Reduced Ejection Fraction. JACC Advances. 4(11). 102195–102195.
3.
DeJong, Colette, Kosuke Inoue, Matthew S. Durstenfeld, et al.. (2025). Direct-to-Physician Marketing and Uptake of Optimal Medical Therapy for Heart Failure With Reduced Ejection Fraction. JACC Heart Failure. 13(7). 102380–102380.
6.
Haghighat, Leila, Colette DeJong, & John R. Teerlink. (2024). New and future heart failure drugs. Nature Cardiovascular Research. 3(12). 1389–1407. 2 indexed citations
7.
Hamo, Carine, Colette DeJong, Lars H. Lund, et al.. (2024). Heart failure with preserved ejection fraction. Nature Reviews Disease Primers. 10(1). 55–55. 38 indexed citations breakdown →
8.
DeJong, Colette, Mansi Agarwal, Matthew S. Durstenfeld, et al.. (2024). Stakeholder Perspectives on a Heart Failure With Reduced Ejection Fraction Polypill: A Multi-Center Mixed Methods Study. Circulation Cardiovascular Quality and Outcomes. 17(11). e011121–e011121. 2 indexed citations
9.
Kazi, Dhruv S., Colette DeJong, Randi Chen, Rishi K. Wadhera, & Chien‐Wen Tseng. (2023). The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease. Journal of the American College of Cardiology. 81(21). 2103–2111. 14 indexed citations
10.
Kazi, Dhruv S., Colette DeJong, Rishi K. Wadhera, Randi Chen, & Chien‐Wen Tseng. (2023). PROJECTED IMPACT OF THE INFLATION REDUCTION ACT ON OUT-OF-POCKET DRUG COSTS FOR MEDICARE PART D BENEFICIARIES WITH CARDIOVASCULAR DISEASE. Journal of the American College of Cardiology. 81(8). 273–273. 1 indexed citations
11.
Tseng, Chien‐Wen, et al.. (2021). Patients' Compliance With Quarantine Requirements for Exposure or Potential Symptoms of COVID-19.. PubMed. 80(11). 276–282. 7 indexed citations
12.
DeJong, Colette, Matthew A. Spinelli, Hideaki Okochi, & Monica Gandhi. (2021). Tenofovir-based PrEP for COVID-19: an untapped opportunity?. AIDS. 35(9). 1509–1511. 10 indexed citations
13.
Anderson, Timothy S., Colette DeJong, Chester B. Good, & Walid F. Gellad. (2020). Disclosure of Article Funding and Conflicts of Interest in High-Impact Clinical Journals. Journal of General Internal Medicine. 35(4). 1345–1347. 1 indexed citations
14.
DeJong, Colette, et al.. (2020). Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part D. JAMA Internal Medicine. 180(12). 1696–1696. 33 indexed citations
15.
DeJong, Colette & Robert Steinbrook. (2019). Shining a Light on Industry Payments to Health Care Professionals Who Are Not Physicians. JAMA Internal Medicine. 179(10). 1432–1432. 1 indexed citations
16.
Marafino, Ben J., Miran Park, Jason M. Davies, et al.. (2018). Validation of Prediction Models for Critical Care Outcomes Using Natural Language Processing of Electronic Health Record Data. JAMA Network Open. 1(8). e185097–e185097. 75 indexed citations
17.
Schoenfeld, Adam J., Jason M. Davies, Ben J. Marafino, et al.. (2016). Variation in Quality of Urgent Health Care Provided During Commercial Virtual Visits. JAMA Internal Medicine. 176(5). 635–635. 52 indexed citations
18.
DeJong, Colette, et al.. (2016). Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Internal Medicine. 176(8). 1114–1114. 327 indexed citations breakdown →
19.
DeJong, Colette, Catherine R. Lucey, & R. Adams Dudley. (2015). Incorporating a New Technology While Doing No Harm, Virtually. JAMA. 314(22). 2351–2351. 29 indexed citations
20.
DeJong, Colette, John Santa, & R. Adams Dudley. (2014). Websites That Offer Care Over the Internet. JAMA. 311(13). 1287–1287. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026